We are an innovative company offering unique, new-generation telemedicine solutions. Telemedicine, based on technology enabling the patient’s health condition to be monitored at a distance, is one of the fastest-growing industries in the world. According to forecasts presented in the mHealth Intelligence report, the value of the global mHealth market (mobile healthcare applications) will grow from $10.3bn in 2016 to $49.1bn in 2020.
Using the HoloLens technology developed by Microsoft, we enable interventional cardiologists to diagnose the patient’s heart in real time based on holographic data transmitted by our system.
Continual creation of new innovations is made possible by the engagement and passion of the firm’s scientific personnel. The computer scientists, programmers, engineers and managers of MedApp create a team capable of competing confidently with its peers.
Thanks to numerous appearances at scientific and industry conferences in Poland and abroad, including the United States and Asia, we have built our position as experts in the telemedicine sector. Our listing on the NewConnect market of the Warsaw Stock Exchange provides additional credibility to our initiatives. It not only gives us access to capital, but also provides us with a market valuation.